|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Aegerion Pharmaceuticals, Inc.
| | | Phone: | (617) 500-7867 | Fax: | (617) 945-7968 | Year Established: | 2005 | Ticker: | AEGR | Exchange: | NASDAQ | Main Contact: | Mary Szela, CEO | | Other Contacts: | Remi Menes, Chief Commercial Officer Sam Yonren, MD, VP, Global Head of Drug Safety Jerome Premmereur, MD, VP, Global Head of Medical Affairs Mark Rothera, Global President Gregory Perry, CFO Anne Marie Cook, Senior VP, General Counsel and Secretary Martha Carter, Chief Regulatory Officer
| | Company Description | Aegerion Pharmaceuticals is committed to changing the way rare, life-threatening disorders are treated. Aegerion is an emerging biopharmaceutical company focused on the development and commercialization of novel, breakthrough therapeutics to treat debilitating and often fatal rare diseases. Aegerion is motivated by its commitment to patients first. Aegerion is also attentive to its core values of integrity, innovation, responsibility to healthcare providers, development of employees and always — scientific and clinical excellence. | |
|
|
|
|
|